APV/FIP Joint-Workshop in Nuremberg
Dissolution testing is an important tool from early development to life cycle management of a drug product. With the aim to give an update on the
application of dissolution testing in assessing critical formulation attributes with regard to bioavailability of the respective drug product, on September 26-27, 2017, on the initiative of Dr. Horst-Dieter Friedel who is co- chair of the International Pharmaceutical Federation (FIP) Focus Group on Dissolution/In Vitro Drug Release, the International Association for Pharmaceutical Technology (APV) and FIP organized a joint workshop on oral biopharmaceutic tools in Nuremberg. The workshop was planned by Dr. Jennifer Dressman, the chair of the APV Focus Group on Biopharmaceutics and Pharmacokinetics, and Dr. Sandra Klein, also represeting APV, and, Dr. Christos Reppas and Dr. Horst-Dieter Friedel from the FIP Focus Group on Dissolution/In Vitro Drug Release. The workshop had a total of 57 attendees.
Ernst Moritz Arndt University Greifswald Department of Pharmacy
Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport
Recommended for you